Attached files
file | filename |
---|---|
EX-31.2 - EXHIBIT 31.2 - AYTU BIOPHARMA, INC | ex_223935.htm |
EX-31.1 - EXHIBIT 31.1 - AYTU BIOPHARMA, INC | ex_218566.htm |
EX-10.1 - EXHIBIT 10.1 - AYTU BIOPHARMA, INC | ex_224614.htm |
10-Q - FORM 10-Q - AYTU BIOPHARMA, INC | aytu20201219_10q.htm |
Ex. 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S. C. SECTION 1350 AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the filing of the quarterly report on Form 10-Q for the quarter ended December 31, 2020 (the “Report”) by Aytu BioScience, Inc. (the “Company”), each of the undersigned hereby certifies that:
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: February 11, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Joshua R. Disbrow |
|
|
|
Joshua R. Disbrow |
|
|
|
Chief Executive Officer (Principal Executive Officer) |
|
Date: February 11, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ David A. Green |
|
|
|
David A. Green |
|
|
|
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
|